Quercetin — Expert Claims
Extracted from publicly available podcast transcripts and videos. Each claim is attributed and sourced.
Expert Consensus
Dose divergence: Experts recommend different amounts (250-500milligrams, 500milligrams). Check the Stack & Timing tab for study-backed dosing ranges.
Claims are extracted using AI (Claude) from publicly available transcripts, each attributed to its source with an extraction-confidence rating (high / medium / low) so it can be verified, then compared against PubMed research. See how our data is made.
92 expert mentions
“For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.”
For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.
None of the 10 retrieved studies provide extractable key findings, populations, or limitations, making it impossible to directly evaluate the specific dose range of 250–500 mg of a bioavailable querce…
“For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.”
For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.
None of the 10 retrieved studies provide extractable key findings, population data, or dose-specific details that directly evaluate the 250–500 mg quercetin range for daily anti-inflammatory or antiox…
“For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.”
For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.
The available evidence provides indirect support for the 250–500 mg range as a reasonable dosing window. The safety review (PMID: 29127724) notes that quercetin supplements are commonly marketed at do…
“For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.”
For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.
None of the 10 retrieved studies provide specific key findings, populations, or limitations data that can be directly evaluated, making it impossible to confirm or contradict the specific dose range (…
“For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.”
For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable quercetin formulation are more typical.
The research literature supports quercetin's anti-inflammatory and antioxidant properties broadly, and the safety review (PMID: 29127724) and therapeutic potential review (PMID: 38258783) note that qu…
“For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.”
For daily anti-inflammatory and antioxidant support, lower doses of 250 to 500 milligrams of a bioavailable formulation are more typical.
The 10 provided studies — spanning reviews, systematic reviews, and one meta-analysis — contain no extractable key findings, populations, or limitations as presented, making direct comparison impossib…
“Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.”
Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.
None of the 10 retrieved studies directly address the bioavailability of quercetin phytosome formulations compared to standard quercetin, nor do any report a specific '20-fold higher bioavailability'…
“It's been studied for decades as an antioxidant and anti-inflammatory”
Quercetin has been studied for decades as an antioxidant and anti-inflammatory.
The claim that quercetin has been studied for decades as an antioxidant and anti-inflammatory is well-supported by the breadth and diversity of the provided literature. Multiple review articles (e.g.,…
“the most exciting recent research positions quercetin as a senolytic — a compound that selectively eliminates senescent cells.”
The most exciting recent research positions quercetin as a senolytic — a compound that selectively eliminates senescent cells.
None of the 10 provided studies directly address quercetin's senolytic activity or its ability to selectively eliminate senescent cells. The retrieved literature covers quercetin's effects on inflamma…
“The work from James Kirkland's lab at Mayo Clinic has shown that quercetin, particularly in combination with dasatinib, can selectively eliminate senescent cells in both mice and humans.”
Research from James Kirkland's lab at Mayo Clinic has shown that quercetin, particularly in combination with dasatinib, can selectively eliminate senescent cells in both mice and humans.
None of the 10 provided studies address the specific claim about quercetin combined with dasatinib as a senolytic agent targeting senescent cells in mice or humans from James Kirkland's lab at Mayo Cl…
“The human trials showing that senolytic treatment reduced senescent cell burden and improved physical function are genuinely groundbreaking.”
Human trials have shown that senolytic treatment with quercetin (and dasatinib) reduced senescent cell burden and improved physical function.
None of the 10 provided studies directly address the specific claim that senolytic treatment with quercetin and dasatinib reduces senescent cell burden or improves physical function in humans. The ret…
“the protocols used in research typically involve intermittent high-dose administration — for example, 500 milligrams twice daily for two to three days, then a gap of weeks to months — rather than daily low-dose supplementation.”
For senolytic purposes, research protocols typically use intermittent high-dose administration — 500 milligrams twice daily for two to three days, followed by a gap of weeks to months — rather than daily low-dose supplementation.
None of the 10 provided studies directly address senolytic dosing protocols for quercetin or any compound. The studies cover topics such as inflammation, bone metabolism, cardiovascular risk, rheumato…
“Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.”
Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.
None of the 10 retrieved studies directly evaluate quercetin phytosome formulations or provide specific bioavailability comparisons between phytosome and standard quercetin forms. While PMID 40037045…
“The human trials showing that senolytic treatment reduced senescent cell burden and improved physical function are genuinely groundbreaking.”
Human trials have shown that senolytic treatment with quercetin (and dasatinib) reduced senescent cell burden and improved physical function.
None of the 10 provided studies directly address the claim about senolytic treatment with quercetin and dasatinib reducing senescent cell burden or improving physical function in human trials. The ret…
“The human trials showing that senolytic treatment reduced senescent cell burden and improved physical function are genuinely groundbreaking.”
Human trials have shown that senolytic treatment with quercetin (and dasatinib) reduced senescent cell burden and improved physical function.
None of the 10 provided studies directly address the claim about senolytic treatment with quercetin (and dasatinib) reducing senescent cell burden or improving physical function in humans. The retriev…
“It's been studied for decades as an antioxidant and anti-inflammatory”
Quercetin has been studied for decades as an antioxidant and anti-inflammatory.
The claim that quercetin has been studied for decades as an antioxidant and anti-inflammatory is supported by the breadth and diversity of the provided literature. Multiple systematic reviews and meta…
“Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.”
Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.
None of the 10 provided studies directly examine quercetin phytosome formulations or report bioavailability comparisons between phytosome and standard quercetin forms. While PMID 40037045 is a systema…
“It's been studied for decades as an antioxidant and anti-inflammatory”
Quercetin has been studied for decades as an antioxidant and anti-inflammatory.
The expert's claim that quercetin has been studied for decades as an antioxidant and anti-inflammatory is supported by the breadth and diversity of the provided literature, which spans reviews, meta-a…
“the most exciting recent research positions quercetin as a senolytic — a compound that selectively eliminates senescent cells.”
The most exciting recent research positions quercetin as a senolytic — a compound that selectively eliminates senescent cells.
None of the 10 retrieved studies address quercetin's senolytic activity — the specific mechanism claimed by Rhonda Patrick involving selective elimination of senescent cells. The available literature…
“the protocols used in research typically involve intermittent high-dose administration — for example, 500 milligrams twice daily for two to three days, then a gap of weeks to months — rather than daily low-dose supplementation.”
For senolytic purposes, research protocols typically use intermittent high-dose administration — 500 milligrams twice daily for two to three days, followed by a gap of weeks to months — rather than daily low-dose supplementation.
None of the 10 provided studies address senolytic dosing protocols for quercetin. The studies cover topics such as allergy, bioavailability, exercise recovery, blood pressure, diabetes, endometriosis,…
“The work from James Kirkland's lab at Mayo Clinic has shown that quercetin, particularly in combination with dasatinib, can selectively eliminate senescent cells in both mice and humans.”
Research from James Kirkland's lab at Mayo Clinic has shown that quercetin, particularly in combination with dasatinib, can selectively eliminate senescent cells in both mice and humans.
None of the 10 provided studies address the specific claim about quercetin combined with dasatinib as a senolytic agent from James Kirkland's lab at Mayo Clinic. The retrieved literature covers querce…
“the most exciting recent research positions quercetin as a senolytic — a compound that selectively eliminates senescent cells.”
The most exciting recent research positions quercetin as a senolytic — a compound that selectively eliminates senescent cells.
None of the 10 retrieved studies address quercetin's senolytic properties or its ability to selectively eliminate senescent cells. The available literature covers quercetin in contexts such as blood p…
“The work from James Kirkland's lab at Mayo Clinic has shown that quercetin, particularly in combination with dasatinib, can selectively eliminate senescent cells in both mice and humans.”
Research from James Kirkland's lab at Mayo Clinic has shown that quercetin, particularly in combination with dasatinib, can selectively eliminate senescent cells in both mice and humans.
None of the 10 provided studies address the specific claim about quercetin combined with dasatinib as a senolytic agent from James Kirkland's lab at Mayo Clinic. The retrieved literature covers querce…
“the protocols used in research typically involve intermittent high-dose administration — for example, 500 milligrams twice daily for two to three days, then a gap of weeks to months — rather than daily low-dose supplementation.”
For senolytic purposes, research protocols typically use intermittent high-dose administration — 500 milligrams twice daily for two to three days, followed by a gap of weeks to months — rather than daily low-dose supplementation.
None of the 10 provided studies address senolytic dosing protocols for quercetin. The research provided covers topics such as allergic immune response, bioavailability, exercise-induced muscle damage,…
“the most exciting recent research positions quercetin as a senolytic — a compound that selectively eliminates senescent cells.”
The most exciting recent research positions quercetin as a senolytic — a compound that selectively eliminates senescent cells.
None of the 10 provided studies address quercetin's senolytic activity — the specific mechanism claimed by Rhonda Patrick. The retrieved literature covers quercetin's effects on allergy, blood pressur…
“It's been studied for decades as an antioxidant and anti-inflammatory”
Quercetin has been studied for decades as an antioxidant and anti-inflammatory.
The claim that quercetin has been studied for decades as an antioxidant and anti-inflammatory is supported by the breadth and diversity of the provided literature. Multiple reviews and meta-analyses (…
“The human trials showing that senolytic treatment reduced senescent cell burden and improved physical function are genuinely groundbreaking.”
Human trials have shown that senolytic treatment with quercetin (and dasatinib) reduced senescent cell burden and improved physical function.
None of the 10 retrieved studies directly address the specific claim about senolytic treatment with quercetin and dasatinib reducing senescent cell burden or improving physical function in human trial…
“The work from James Kirkland's lab at Mayo Clinic has shown that quercetin, particularly in combination with dasatinib, can selectively eliminate senescent cells in both mice and humans.”
Research from James Kirkland's lab at Mayo Clinic has shown that quercetin, particularly in combination with dasatinib, can selectively eliminate senescent cells in both mice and humans.
None of the 10 provided studies address senolytic activity, senescent cell clearance, or the dasatinib-quercetin combination. The retrieved literature covers quercetin's effects on allergy, blood pres…
“Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.”
Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.
None of the 10 retrieved studies directly address the specific claim that quercetin phytosome formulations achieve 20-fold higher bioavailability compared to standard quercetin. While PMID 40037045 is…
“the protocols used in research typically involve intermittent high-dose administration — for example, 500 milligrams twice daily for two to three days, then a gap of weeks to months — rather than daily low-dose supplementation.”
For senolytic purposes, research protocols typically use intermittent high-dose administration — 500 milligrams twice daily for two to three days, followed by a gap of weeks to months — rather than daily low-dose supplementation.
None of the 10 provided studies directly address senolytic dosing protocols for quercetin or any compound. The studies cover topics such as quercetin's effects on blood pressure, bone metabolism, rheu…
“It's been studied for decades as an antioxidant and anti-inflammatory”
Quercetin has been studied for decades as an antioxidant and anti-inflammatory.
Multiple lines of evidence from the provided literature directly support the claim that quercetin has been studied for decades as an antioxidant and anti-inflammatory. PMID 26999194 (review) explicitl…
“the most exciting recent research positions quercetin as a senolytic — a compound that selectively eliminates senescent cells.”
The most exciting recent research positions quercetin as a senolytic — a compound that selectively eliminates senescent cells.
None of the 20 studies provided directly address quercetin's senolytic activity — that is, its ability to selectively eliminate senescent cells. While the literature provided covers quercetin's anti-i…
“The work from James Kirkland's lab at Mayo Clinic has shown that quercetin, particularly in combination with dasatinib, can selectively eliminate senescent cells in both mice and humans.”
Research from James Kirkland's lab at Mayo Clinic has shown that quercetin, particularly in combination with dasatinib, can selectively eliminate senescent cells in both mice and humans.
None of the 20 published research sources provided address the specific claim about quercetin combined with dasatinib (the 'senolytic' combination) for eliminating senescent cells from James Kirkland'…
“The human trials showing that senolytic treatment reduced senescent cell burden and improved physical function are genuinely groundbreaking.”
Human trials have shown that senolytic treatment with quercetin (and dasatinib) reduced senescent cell burden and improved physical function.
None of the 20 studies provided directly address the use of quercetin as a senolytic agent (alone or in combination with dasatinib) for reducing senescent cell burden or improving physical function in…
“Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.”
Quercetin phytosome formulations have demonstrated 20-fold higher bioavailability than standard quercetin.
The meta-analysis on quercetin bioavailability (PMID: 40037045) directly assessed methods to improve quercetin bioavailability across 31 human intervention studies, confirming that formulation signifi…
“the protocols used in research typically involve intermittent high-dose administration — for example, 500 milligrams twice daily for two to three days, then a gap of weeks to months — rather than daily low-dose supplementation.”
For senolytic purposes, research protocols typically use intermittent high-dose administration — 500 milligrams twice daily for two to three days, followed by a gap of weeks to months — rather than daily low-dose supplementation.
None of the 20 studies in the provided literature address senolytic protocols or intermittent high-dose quercetin dosing regimens. The research covers quercetin's anti-inflammatory, antioxidant, cardi…
“the most exciting recent research positions quercetin as a senolytic — a compound that selectively eliminates senescent cells”
Quercetin acts as a senolytic — a compound that selectively eliminates senescent cells.
None of the 20 published studies provided in the evidence base specifically address quercetin's senolytic activity — that is, its ability to selectively eliminate senescent cells. While several review…
“The human trials showing that senolytic treatment reduced senescent cell burden and improved physical function are genuinely groundbreaking.”
Human trials of senolytic treatment with quercetin (plus dasatinib) reduced senescent cell burden and improved physical function.
None of the 20 provided studies address senolytic treatment combining quercetin with dasatinib, senescent cell burden reduction, or physical function outcomes in human trials. The available literature…
“the protocols used in research typically involve intermittent high-dose administration — for example, 500 milligrams twice daily for two to three days, then a gap of weeks to months — rather than daily low-dose supplementation”
For senolytic purposes, research protocols typically use intermittent high-dose quercetin — 500 mg twice daily for two to three days, followed by a gap of weeks to months — rather than daily low-dose supplementation.
None of the 20 studies provided address senolytic protocols, intermittent high-dose quercetin dosing regimens, or the specific 500 mg twice-daily cyclical approach described by Rhonda Patrick. The ava…
“The work from James Kirkland's lab at Mayo Clinic has shown that quercetin, particularly in combination with dasatinib, can selectively eliminate senescent cells in both mice and humans.”
Research from James Kirkland's lab at Mayo Clinic showed that quercetin, particularly in combination with dasatinib, can selectively eliminate senescent cells in both mice and humans.
None of the 20 published research summaries provided address the specific claim about James Kirkland's lab at Mayo Clinic or the quercetin-dasatinib combination as a senolytic therapy targeting senesc…
“The human trials showing that senolytic treatment reduced senescent cell burden and improved physical function are genuinely groundbreaking.”
Human trials of senolytic treatment with quercetin (and dasatinib) reduced senescent cell burden and improved physical function.
None of the 20 published research articles provided address the specific claim about quercetin used as a senolytic agent (in combination with dasatinib) to reduce senescent cell burden or improve phys…
“That was discovered first as a senolytic by Jim Kirkland at the Mayo Clinic who combined it with a drug called dasatinib. And together, those two molecules are potent killers of senescent cells.”
Quercetin was discovered as a senolytic by Jim Kirkland at the Mayo Clinic, who combined it with dasatinib, and together the two molecules are potent killers of senescent cells.
“we've had some randomized controlled trials with humans and quercetin. The effects are Uh reduces uh liver steatosis, a fatty liver, uh as well as other uh effects like inflammation in the body.”
Randomized controlled trials in humans with quercetin have shown it reduces liver steatosis (fatty liver) and inflammation in the body.
“That was discovered first as a senolytic by Jim Kirkland at the Mayo Clinic who combined it with a drug called dasatinib.”
Quercetin was first identified as a senolytic by Jim Kirkland at the Mayo Clinic, who combined it with the drug dasatinib.
“We've had some randomized controlled trials with humans and quercetin. The effects are Uh reduces uh liver steatosis.”
There have been randomized controlled trials with quercetin in humans, with effects including reduction of liver steatosis.
“There were others, quercetin, fisetin, which are actually now used by others for longevity. But resveratrol got most of the attention because it's found in red wine.”
Quercetin was among the original molecules identified as sirtuin activators in early yeast experiments, alongside resveratrol and fisetin.
“You can actually see that the number of senescent cells in the body goes away when you treat with quercetin and dasatinib.”
Treatment with quercetin and dasatinib visibly reduces the number of senescent cells in the body.
“those have been put into mice and into humans where they are showing really remarkable effects in treating age-related diseases.”
Quercetin combined with dasatinib has shown remarkable effects in treating age-related diseases in both mice and humans.
“the polyphenols that come from plants, quercetin, fisetin, um resveratrol, even curcumin, uh especially curcumin, they're like brick dust. They don't they don't get absorbed. They're they're they're crunchy. So, you have to mix them with something, olive oil or yogurt, so that they they get absorbed. And I know this from human clinical trials.”
Quercetin, like resveratrol and other polyphenols, is poorly absorbed and must be mixed with olive oil or yogurt to improve absorption.
“And that's what fisetin and quercetin appear to do. They do uh in the dish and in mice.”
Quercetin's senolytic effects have been demonstrated in cell cultures and in mice.
“And together, those two molecules are potent killers of senescent cells. And those have been put into mice and into humans where they are showing really remarkable effects in treating age-related diseases.”
Quercetin combined with dasatinib are potent killers of senescent cells, showing remarkable effects in treating age-related diseases in both mice and humans.
“The rationale is that senolytics need to clear senescent cells, and then you wait for new senescent cells to accumulate before treating again.”
The rationale for intermittent senolytic dosing of quercetin is that it needs to clear senescent cells, and then you wait for new senescent cells to accumulate before treating again.
None of the 20 listed studies address the senolytic mechanism of quercetin, intermittent dosing rationale, or senescent cell clearance. The available literature covers quercetin's anti-allergic proper…
“The rationale is that senolytics need to clear senescent cells, and then you wait for new senescent cells to accumulate before treating again.”
The rationale for intermittent senolytic dosing is that quercetin needs to clear senescent cells, and then you wait for new senescent cells to accumulate before treating again.
None of the 10 provided studies address the mechanistic rationale for intermittent senolytic dosing of quercetin, senescent cell clearance, or senescent cell re-accumulation kinetics. The studies focu…
“The bioavailability challenge with quercetin is real — like many polyphenols, it's poorly absorbed in standard form.”
Quercetin has a real bioavailability challenge — like many polyphenols, it is poorly absorbed in standard form.
None of the 10 provided studies directly address quercetin's bioavailability or absorption mechanisms — all key findings, populations, and limitations fields are listed as 'None,' preventing any direc…
“quercetin is a zinc ionophore, meaning it helps transport zinc into cells, which may explain some of the antiviral research on quercetin plus zinc combinations.”
Quercetin is a zinc ionophore, meaning it helps transport zinc into cells, which may explain some of the antiviral research on quercetin plus zinc combinations.
None of the 10 provided studies directly address quercetin's proposed mechanism as a zinc ionophore or its combination with zinc for antiviral purposes. The retrieved literature covers quercetin's eff…
“The bioavailability challenge with quercetin is real — like many polyphenols, it's poorly absorbed in standard form.”
Quercetin has a real bioavailability challenge — like many polyphenols, it is poorly absorbed in standard form.
The claim that quercetin has poor bioavailability in standard form is broadly consistent with the scientific literature and is implicitly supported by the existence of a systematic review and meta-ana…
“The rationale is that senolytics need to clear senescent cells, and then you wait for new senescent cells to accumulate before treating again.”
The rationale for intermittent senolytic dosing is that quercetin needs to clear senescent cells, and then you wait for new senescent cells to accumulate before treating again.
None of the 10 provided studies address the mechanistic rationale for intermittent senolytic dosing with quercetin. The studies retrieved cover quercetin's roles in allergy, blood pressure, diabetes,…
“quercetin is a zinc ionophore, meaning it helps transport zinc into cells, which may explain some of the antiviral research on quercetin plus zinc combinations.”
Quercetin is a zinc ionophore, meaning it helps transport zinc into cells, which may explain some of the antiviral research on quercetin plus zinc combinations.
None of the 10 provided studies address quercetin's proposed zinc ionophore mechanism or the quercetin-plus-zinc antiviral combination. The retrieved literature covers topics such as blood pressure, b…
“They are what are called senolytic. Kill senescent cells... And that's what fisetin and quercetin appear to do.”
Quercetin is senolytic — it kills senescent cells.
“The bioavailability challenge with quercetin is real — like many polyphenols, it's poorly absorbed in standard form.”
Quercetin has a real bioavailability challenge — like many polyphenols, it is poorly absorbed in standard form.
The claim that quercetin has poor bioavailability in standard form is broadly consistent with established pharmacokinetic knowledge of polyphenols, and the existence of a strong-quality meta-analysis…
“quercetin, uh which is a molecule related to resveratrol, which is also uh suppresses the activity of senescent cells.”
Quercetin suppresses the activity of senescent cells.
“Quercetin is also more bioavailable when consumed with fat.”
Quercetin is more bioavailable when consumed with fat.
None of the 10 retrieved studies directly address the specific mechanistic claim that quercetin bioavailability is enhanced when consumed with dietary fat. The most relevant study (PMID: 40037045), a…
“The rationale is that senolytics need to clear senescent cells, and then you wait for new senescent cells to accumulate before treating again.”
The rationale for intermittent senolytic dosing is that quercetin needs to clear senescent cells, and then you wait for new senescent cells to accumulate before treating again.
None of the 10 provided studies address the mechanistic rationale for intermittent senolytic dosing with quercetin. The retrieved literature covers quercetin's effects on inflammation, cardiovascular…
“quercetin is a zinc ionophore, meaning it helps transport zinc into cells, which may explain some of the antiviral research on quercetin plus zinc combinations.”
Quercetin is a zinc ionophore, meaning it helps transport zinc into cells, which may explain some of the antiviral research on quercetin plus zinc combinations.
None of the 10 provided studies address quercetin's proposed mechanism as a zinc ionophore or its combination with zinc for antiviral effects. The retrieved literature covers quercetin's effects on al…
“Quercetin is also more bioavailable when consumed with fat.”
Quercetin is more bioavailable when consumed with fat.
None of the 10 provided studies directly address the bioavailability of quercetin in relation to co-consumption with dietary fat. The retrieved literature spans reviews and systematic reviews on querc…
“The bioavailability challenge with quercetin is real — like many polyphenols, it's poorly absorbed in standard form.”
Quercetin is poorly absorbed in standard form, like many polyphenols, presenting a real bioavailability challenge.
The expert's claim that quercetin is poorly absorbed in standard form is directly supported by multiple studies in the provided literature. The systematic review and meta-analysis on quercetin bioavai…
“The rationale is that senolytics need to clear senescent cells, and then you wait for new senescent cells to accumulate before treating again.”
The rationale for intermittent senolytic dosing is that the compound clears senescent cells, and then one waits for new senescent cells to accumulate before treating again.
None of the 20 published studies provided address senolytic compounds, senescent cell biology, or intermittent senolytic dosing rationale. The research corpus focuses exclusively on quercetin's anti-i…
“Quercetin is also more bioavailable when consumed with fat.”
Quercetin is more bioavailable when consumed with fat.
None of the 10 provided studies contain extractable key findings relevant to the specific mechanistic claim that quercetin bioavailability is enhanced when consumed with fat. While PMID 40037045 is a…
“The bioavailability challenge with quercetin is real — like many polyphenols, it's poorly absorbed in standard form.”
Quercetin has a real bioavailability challenge — like many polyphenols, it is poorly absorbed in standard form.
The expert's claim that quercetin has poor bioavailability in standard form is broadly consistent with established pharmacokinetic knowledge about polyphenols, and the existence of a strong-quality me…
“The bioavailability challenge with quercetin is real — like many polyphenols, it's poorly absorbed in standard form.”
Quercetin has poor bioavailability in standard form, like many polyphenols.
The expert's claim that quercetin has poor bioavailability in standard form is directly supported by the systematic review and meta-analysis (PMID: 40037045), a strong-quality study evaluating 31 huma…
“Quercetin is also more bioavailable when consumed with fat.”
Quercetin is more bioavailable when consumed with fat.
None of the 10 retrieved studies directly examine the effect of co-consumption with dietary fat on quercetin bioavailability. The most relevant study (PMID 40037045) is a systematic review and meta-an…
“quercetin is a zinc ionophore, meaning it helps transport zinc into cells, which may explain some of the antiviral research on quercetin plus zinc combinations.”
Quercetin is a zinc ionophore, meaning it helps transport zinc into cells, which may explain some of the antiviral research on quercetin plus zinc combinations.
None of the 10 provided studies address the specific mechanistic claim that quercetin acts as a zinc ionophore or facilitates intracellular zinc transport. The retrieved literature covers quercetin's…
“The bioavailability challenge with quercetin is real — like many polyphenols, it's poorly absorbed in standard form.”
Quercetin has a real bioavailability challenge — like many polyphenols, it is poorly absorbed in standard form.
The expert's claim about quercetin's poor bioavailability in standard form is directly supported by multiple studies in the provided literature. Most notably, the meta-analysis and systematic review (…
“Quercetin is also more bioavailable when consumed with fat.”
Quercetin is more bioavailable when consumed with fat.
The bioavailability meta-analysis (PMID: 40037045), which evaluated 31 human intervention studies, is the most directly relevant evidence and found that quercetin bioavailability is affected by severa…
“The rationale is that senolytics need to clear senescent cells, and then you wait for new senescent cells to accumulate before treating again.”
The rationale for intermittent senolytic dosing is that quercetin needs to clear senescent cells, and then you wait for new senescent cells to accumulate before treating again.
None of the 20 listed studies directly address the senolytic mechanism of quercetin, intermittent dosing rationale, or senescent cell clearance. The provided literature focuses on quercetin's anti-inf…
“The rationale is that senolytics need to clear senescent cells, and then you wait for new senescent cells to accumulate before treating again.”
The rationale for intermittent senolytic dosing is that quercetin needs to clear senescent cells, and then you wait for new senescent cells to accumulate before treating again.
None of the 10 provided studies address the mechanistic rationale for intermittent senolytic dosing with quercetin. The retrieved literature covers quercetin's roles in allergy, blood pressure, diabet…
“quercetin is a zinc ionophore, meaning it helps transport zinc into cells, which may explain some of the antiviral research on quercetin plus zinc combinations.”
Quercetin is a zinc ionophore, meaning it helps transport zinc into cells, which may explain some of the antiviral research on quercetin plus zinc combinations.
None of the 20 published studies provided directly address quercetin's role as a zinc ionophore or the quercetin-plus-zinc antiviral combination mechanism. The available literature covers quercetin's…
“I'm particularly interested in the combination of quercetin with zinc”
Rhonda Patrick expresses particular personal interest in the combination of quercetin with zinc.
The claim is a personal anecdote about Rhonda Patrick's interest in combining quercetin with zinc, not a scientific assertion about efficacy. None of the 20 studies provided examine the quercetin-zinc…
“I'm particularly interested in the combination of quercetin with zinc”
Rhonda Patrick expresses particular personal interest in the combination of quercetin with zinc.
The claim is a personal anecdote about Rhonda Patrick's individual interest in combining quercetin with zinc, not a scientific claim about efficacy or mechanisms. None of the 10 provided studies addre…
“I'm particularly interested in the combination of quercetin with zinc”
Rhonda Patrick expresses particular personal interest in the combination of quercetin with zinc.
The claim is a personal anecdote about Rhonda Patrick's individual interest in combining quercetin with zinc, not a scientific assertion subject to direct empirical verification. None of the 10 provid…
“I've added um quercetin, uh which is a molecule related to resveratrol, which is also uh suppresses the activity of senescent cells.”
David Sinclair personally takes quercetin as part of his supplement regimen.
“I'm particularly interested in the combination of quercetin with zinc”
Rhonda Patrick expresses particular personal interest in the combination of quercetin with zinc.
The claim is a personal anecdote about Rhonda Patrick's subjective interest in combining quercetin with zinc, not a scientific assertion about efficacy or safety. None of the 10 provided studies addre…
“I'm particularly interested in the combination of quercetin with zinc”
Rhonda Patrick expresses personal interest in the combination of quercetin with zinc.
The claim is a personal anecdote about Rhonda Patrick's interest in combining quercetin with zinc, which is not a scientific claim that can be directly supported or contradicted by the literature prov…
“I'm particularly interested in the combination of quercetin with zinc”
Rhonda Patrick is particularly interested in the combination of quercetin with zinc.
The claim is a personal anecdote about Rhonda Patrick's individual interest in combining quercetin with zinc — it is not a scientific claim about efficacy. None of the 20 studies provided address the…
“I'm particularly interested in the combination of quercetin with zinc”
Rhonda Patrick expresses particular personal interest in the combination of quercetin with zinc.
The claim is a personal anecdote about Rhonda Patrick's individual interest in combining quercetin with zinc, not a scientific claim requiring empirical validation. None of the 10 provided studies exa…
“Quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale.”
Quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale.
Multiple sources in the provided literature directly confirm that quercetin is a flavonoid polyphenol found in common foods. PMID 27187333 explicitly identifies quercetin as a polyphenol from the flav…
“Quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale.”
Quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale.
The claim that quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale is a well-established basic nutritional fact. Multiple reviews and systematic reviews in the pro…
“Quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale.”
Quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale.
The claim that quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale is a well-established botanical and nutritional fact. Multiple reviews in the provided literatur…
“Quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale. It's been studied for decades as an antioxidant and anti-inflammatory”
Quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale, and has been studied for decades as an antioxidant and anti-inflammatory.
Multiple studies in the provided literature directly corroborate the expert's claim. PMID 27187333 explicitly identifies quercetin as a flavonoid (flavonols subgroup) found in onions, apples, and othe…
“Quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale. It's been studied for decades as an antioxidant and anti-inflammatory”
Quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale, studied for decades as an antioxidant and anti-inflammatory.
Multiple reviews in the provided literature directly confirm quercetin's identity as a flavonoid polyphenol (specifically a flavonol subgroup), its presence in foods such as onions, apples, and other…
“Quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale.”
Quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale.
The expert's claim that quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale is a well-established botanical and nutritional fact. Multiple reviews in the provided…
“Quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale.”
Quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale.
The claim that quercetin is a flavonoid polyphenol found in foods like onions, capers, apples, and kale is a well-established basic nutritional fact. Multiple reviews in the provided literature (e.g.,…